1
Ronald T Kurnik, Janet Tamada, Michael Tierney: Chemical signal-impermeable mask. Cygnus, Karl Bozicevic & Reed Bozicevic, April 7, 1998: US05735273 (301 worldwide citation)

A chemical signal-impermeable mask is positioned in the electrolyte flow such that the mask is between a source of chemical signal and a working electrode which senses the chemical signal transported from the source (e.g., by diffusion). The configuration of the mask is such that the mask prevents s ...


2
Woonza Rhee, Donald G Wallace, Alan S Michaels, Ramon A Burns Jr, Louis Fries, Frank DeLustro, Hanne Bentz: Collagen-polymer conjugates. Collagen Corporation, Karl Bozicevic, July 12, 1994: US05328955 (296 worldwide citation)

Pharmaceutically acceptable, non-immunogenic compositions are formed by covalently binding atelopeptide collagen to pharmaceutically pure, synthetic, hydrophilic polymers via specific types of chemical bonds to provide collagen/polymer conjugates. The atelopeptide collagen can be type I, type II or ...


3
Lester John Lloyd, Melissa Ann Prince: Patient interface system with a scale. Alere Incorporated, Karl Bozicevic Bozicevic Field & Francis, June 27, 2000: US06080106 (288 worldwide citation)

A patient interface system for collecting and transferring data from a patient to a remote monitoring system, as well as methods for its use, are provided. The subject system uses: (a) a data collection device with a sensor and an interrogation device; (b) a processing device for processing the coll ...


4
Woonza Rhee, Donald G Wallace, Alan S Michaels, Ramon A Burns Jr, Louis Fries, Frank DeLustro, Hanne Bentz: Biologically inert, biocompatible-polymer conjugates. Collagen Corporation, Karl Bozicevic, June 28, 1994: US05324775 (276 worldwide citation)

Pharmaceutically acceptable, non-immunogenic compositions are formed by covalently binding biologically inactive, natural, biocompatible polymer to pharmaceutically pure, synthetic, hydrophilic polymers via specific types of chemical bonds to provide biocompatible conjugates. The synthetic hydrophil ...


5
Lester J Lloyd, Peter M Lloyd, Reid M Rubsamen, Jeffrey A Schuster: Device and method of creating aerosolized mist of respiratory drug. Aradigm Corporation, Karl Bozicevic Field & Francis Bozicevic, August 10, 1999: US05934272 (246 worldwide citation)

Devices, packaging and methodology for efficiently and repeatably creating aerosolized bursts of a formulation of respiratory drug are disclosed. Devices are hand-held, self-contained units which are automatically actuated at the same release point in a patient's inspiratory flow cycle. The release ...


6
Shimon Weiss, Marcel Bruchez Jr, Paul Alivisatos: Organo luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes. The Regents of the University of California, Karl Bozicevic, Bozicevic Field & Francis, July 23, 2002: US06423551 (224 worldwide citation)

A semiconductor nanocrystal compound is described capable of linking to an affinity molecule. The compound comprises (1) a semiconductor nanocrystal capable of emitting electromagnetic radiation and/or absorbing energy, and/or scattering or diffracting electromagnetic radiation—when excited by an el ...


7
Jeffrey A Schuster, Christopher J Flaim: Temperature controlling device for aerosol drug delivery. Aradigm Corporation, Karl Bozicevic Field & Francis Bozicevic, October 17, 2000: US06131570 (197 worldwide citation)

A portable air temperature controlling device useful for warming air surrounding an aerosolized drug formulation is described. Warming the air of an aerosol makes it possible to reduce the size of aerosol particles produced by an aerosol generation device. Additionally, warming the air forces the si ...


8
Reid M Rubsamen, Lester J Lloyd, Eric T Johansson: Lockout device for controlled release of drug from patient-activated dispenser. Aradigm Corporation, Karl Bozicevic, December 9, 1997: US05694919 (186 worldwide citation)

A method of controlling access to a drug in an aerosol drug delivery device by an electronic lock and key means is disclosed. Access is limited to the intended user by providing the intended user with a uniquely coded, machine readable key means that matches the unique code of the lock means. Contac ...


9
Lester J Lloyd, Peter M Lloyd, Reid M Rubsamen, Jeffrey A Schuster: Device for aerosolized delivery of peptide drugs. Aradigm Corporation, Karl Bozicevic Field & Francis Bozicevic, October 5, 1999: US05960792 (173 worldwide citation)

A method of treating human patients is provided by the intrapulmonary delivery of a pharmaceutically active peptide formulation. The formulation is automatically released in an aerosolized form from a hand-held, self-contained, portable device comprised of a means for automatically releasing a measu ...


10
Carl Ritson, Reid M Rubsamen: Automatic aerosol medication delivery system and methods. Aradigm Corporation, Karl Bozicevic, March 7, 1995: US05394866 (166 worldwide citation)

A portable, battery powered, hand-held system for releasing a controlled dose of aerosol medication for inhalation by a patient including a durable body and a medication cassette inserted in the durable body. The cassette includes a housing for containing a canister of medication, bears an identific ...